PMID- 21387371 OWN - NLM STAT- MEDLINE DCOM- 20110511 LR - 20220321 IS - 1531-8249 (Electronic) IS - 0364-5134 (Print) IS - 0364-5134 (Linking) VI - 69 IP - 2 DP - 2011 Feb TI - Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. PG - 257-68 LID - 10.1002/ana.22317 [doi] AB - OBJECTIVE: Cerebrovascular disease is 1 of the possible mechanisms of the previously reported relationship between Mediterranean-type diet (MeDi) and Alzheimer's disease (AD). We sought to investigate the association between MeDi and MRI infarcts. METHODS: High-resolution structural MRI was collected on 707 elderly 65 years or older community residents of New York with available dietary assessments administered an average of 5.8 years (3.22 standard deviations [SDs]) before the MRI. Participants were divided into 3 groups of adherence to MeDi (low, middle, and high tertiles). We examined the association of increasing adherence to MeDi with presence of infarcts on MRI. Models were run without adjustment, adjusted for basic demographic and clinical factors, and adjusted for vascular risk factors. RESULTS: A total of 222 participants had at least 1 infarct. In the unadjusted model, compared to the low adherence group, those in the moderate MeDi adherence group had a 22% reduced odds of having an infarct (odds ratio [OR], 0.78; 95% confidence interval [CI], 0.55-1.14), while participants in the highest MeDi adherence group had a 36% reduced odds (OR, 0.64; 95% CI, 0.42-0.97; p for trend = 0.04). In adjusted models, the association between MeDi adherence and MRI infarcts remained essentially unchanged. The association of high MeDi adherence with infarcts was comparable to that of hypertension (40% reduced probability), did not vary by infarct size or after excluding patients with dementia (n = 46) or clinical strokes (n = 86). There was no association between MeDi and white matter hyperintensities. INTERPRETATION: Higher adherence to the MeDi is associated with reduced cerebrovascular disease burden. CI - Copyright (c) 2011 American Neurological Association. FAU - Scarmeas, Nikolaos AU - Scarmeas N AD - Taub Institute for Research in Alzheimer's Disease and the Aging Brain, University of California at Davis, Sacramento, USA. ns257@columbia.edu FAU - Luchsinger, Jose A AU - Luchsinger JA FAU - Stern, Yaakov AU - Stern Y FAU - Gu, Yian AU - Gu Y FAU - He, Jing AU - He J FAU - DeCarli, Charlie AU - DeCarli C FAU - Brown, Truman AU - Brown T FAU - Brickman, Adam M AU - Brickman AM LA - eng GR - P01-AG07232/AG/NIA NIH HHS/United States GR - K23 AG029949-01/AG/NIA NIH HHS/United States GR - R01 AG037212/AG/NIA NIH HHS/United States GR - R01 AG028506/AG/NIA NIH HHS/United States GR - P30 AG010129/AG/NIA NIH HHS/United States GR - R01 AG037212-01/AG/NIA NIH HHS/United States GR - K23 AG029949/AG/NIA NIH HHS/United States GR - AG028506/AG/NIA NIH HHS/United States GR - AG029949/AG/NIA NIH HHS/United States GR - R01 AG028506-01A2/AG/NIA NIH HHS/United States GR - R01 AG034189/AG/NIA NIH HHS/United States GR - P01 AG007232-11A1/AG/NIA NIH HHS/United States GR - P01 AG007232/AG/NIA NIH HHS/United States GR - R01 AG034189-01A1/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Ann Neurol JT - Annals of neurology JID - 7707449 SB - IM CIN - Ann Neurol. 2011 Feb;69(2):226-8. PMID: 21387364 CIN - Ann Neurol. 2011 Dec;70(6):1006; author reply 1006-7. PMID: 22190373 MH - Aged MH - Aged, 80 and over MH - Aging/*pathology MH - Analysis of Variance MH - Brain/*pathology/physiopathology MH - Brain Mapping MH - Cerebrovascular Disorders/*etiology/*pathology/physiopathology MH - *Diet, Mediterranean MH - Female MH - Humans MH - Image Processing, Computer-Assisted MH - Magnetic Resonance Imaging MH - Male MH - Motor Activity/physiology MH - Neurologic Examination MH - Neuropsychological Tests MH - New York MH - Risk Factors PMC - PMC3066080 MID - NIHMS279902 COIS- Potential Conflicts of Interest C.D. has grant(s) pending from the NIH. J.H. has received grant(s) from the NIH. J.A.L. has received grant(s) and has grant(s) pending from the NIH. N.S. has received grant(s) from the NIH and has grant(s) pending from the NIH and the Alzheimer's Association. All other authors have nothing to report. EDAT- 2011/03/10 06:00 MHDA- 2011/05/12 06:00 PMCR- 2012/02/01 CRDT- 2011/03/10 06:00 PHST- 2011/03/10 06:00 [entrez] PHST- 2011/03/10 06:00 [pubmed] PHST- 2011/05/12 06:00 [medline] PHST- 2012/02/01 00:00 [pmc-release] AID - 10.1002/ana.22317 [doi] PST - ppublish SO - Ann Neurol. 2011 Feb;69(2):257-68. doi: 10.1002/ana.22317.